Ghanem, H., Cornelison, A. M., Garcia-Manero, G., Kantarjian, H., Ravandi, F., Kadia, T., . . . Jabbour, E. (2013). Decitabine Can Be Safely Reduced after Achievement of Best Objective Response in Patients with Myelodysplastic Syndrome.
Citación estilo ChicagoGhanem, Hady, et al. Decitabine Can Be Safely Reduced After Achievement of Best Objective Response in Patients With Myelodysplastic Syndrome. 2013.
Cita MLAGhanem, Hady, et al. Decitabine Can Be Safely Reduced After Achievement of Best Objective Response in Patients With Myelodysplastic Syndrome. 2013.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.